2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Glofitamab + Obinutuzumab: new trials by email Literature Review of Glofitamab + Obinutuzumab trials Research Report on Glofitamab + Obinutuzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden Glofitamab + Obinutuzumab - Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Lymphoma | Phase 2 | Recruiting | Liling Zhang | 40 | 2025-04-01 | 2026-05-15 |
| Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome Glofitamab + Obinutuzumab - Richter Syndrome | Phase 2 | Recruiting | French Innovative Leukemia Organisation | 40 | 2024-03-21 | 2026-06-30 |
Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1)
French Innovative Leukemia Organisation (1) · Liling Zhang (1)
China (1) · France (1)